IRWD
Ironwood Pharmaceuticals, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +15.3% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q1 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 88 | -4 | 110.50M | $465.13M | +4 | −8 |
| Q1 2026 | 94 | +9 | 125.58M | $394.14M | +11 | −2 |
| Q4 2025 | 85 | +2 | 100.81M | $339.86M | +2 | — |
| Q3 2025 | 17 | 0 | 58.02M | $76.00M | — | — |
| Q2 2025 | 14 | 0 | 58.90M | $42.25M | +1 | −1 |
| Q1 2025 | 11 | 0 | 30.28M | $44.51M | +1 | −1 |
| Q4 2024 | 11 | 0 | 26.27M | $116.38M | +1 | −1 |
| Q3 2024 | 10 | -2 | 15.74M | $64.83M | — | −2 |
| Q2 2024 | 12 | — | 17.55M | $114.44M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 9.94M | +9.6% | $14.61M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | Millennium Management ✦ | 6.36M | +191.7% | $9.35M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (pasivo) | 3.50M | -58.0% | $5.14M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 3.42M | +3.4% | $5.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasivo) | 3.42M | +3.4% | $5.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 2.52M | +535.8% | $3.71M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 2.52M | +535.8% | $3.71M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 2.52M | +535.8% | $3.71M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 2.52M | +535.8% | $3.71M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 2.52M | +535.8% | $3.71M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 1.53M | +33.1% | $2.25M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 1.23M | +42.1% | $1.80M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 940.55K | +67.8% | $1.38M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 940.55K | +67.8% | $1.38M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Marshall Wace ✦ | 557.52K | Nuevo | $819,557 | 0.0% | New | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 171.28K | +78.6% | $252,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 109.72K | +62.0% | $161,294 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 109.72K | +62.0% | $161,294 | 0.0% | ▲ Add | 4 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Marshall Wace | $819,557 | 0.0% |
Posición cerrada
| Norges Bank | $1.12M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 222 tenedores, 159.91M acciones, $533.78M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.